South Carolina ranks tenth in the nation for largest share of annual income spent on GLP-1s like Ozempic, according to a new study. LendingTree subsidiary ValuePenguin claims that the median South Carolina household would spend over 8% of its income for a 2mg dose of the weight loss drug, with a yearly cost of $5,988 at $499 per month. For lower doses dropping the monthly cost to $349 per month, Ozempic would take about 5.8% of household incomes in the state, according to the study. The median household income for South Carolina was $66,818 between 2019-2023, according to the US Census Bureau. South Carolina ranked #21 amongst the contiguous United States in obesity prevalence at 34.6 in 2024, when at least 1 in 4 adults in all US states and territories had obesity, according to findings released by the Centers for Disease Control in 2025.